Results 91 to 100 of about 35,054 (306)

Global escalation in carbapenem-resistant Enterobacterales and carbapenem-resistant Acinetobacter baumannii infections: Serious threat to human health from the pink corner

open access: yesBiomedical and Biotechnology Research Journal, 2023
Rise in carbapenem-resistant Gram-negative bacterial infections, especially among immunocompromised patients in healthcare settings is an imminent threat as they are difficult to treat and result in a prolonged length of hospital stay, frequent treatment
Mohan Bilikallahalli Sannathimmappa
doaj   +1 more source

Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers

open access: yesEuropean Journal of Clinical Microbiology and Infectious Diseases, 2023
The clinical impact of infections due to extended-spectrum β-lactamase (ESBL)- and/or carbapenemase-producing Enterobacterales (Ent) has reached dramatic levels worldwide. Infections due to these multidrug-resistant (MDR) pathogens—especially Escherichia
Edgar I. Campos-Madueno   +7 more
semanticscholar   +1 more source

International Survey on Antibiotic Prophylaxis Approaches for Solid Organ Transplant Recipients and Donors Colonized With Multidrug‐Resistant Organisms

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Background Multidrug‐resistant organism colonization and infections cause significant morbidity and mortality in solid organ transplantation, affecting the perioperative antibiotic management. Yet, international practices for screening and antibiotic prophylaxis in colonized donors and recipients remain poorly defined.
Julia Bini Viotti   +8 more
wiley   +1 more source

Fosfomycin susceptibility testing and resistance mechanisms in Enterobacterales in South Africa

open access: yesAfrican Journal of Laboratory Medicine
Background: Fosfomycin treatment of urinary tract infections is increasingly attractive due to escalating antibiotic resistance rates among urinary pathogens.
Jessica S. Hurwitz   +3 more
doaj   +1 more source

Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine [PDF]

open access: yes, 2023
Cefiderocol susceptibility testing represents a major challenge for clinical microbiology. Although disc diffusion showed robustness to test cefiderocol susceptibility, large areas of technical uncertainty (ATU) are reported by current EUCAST breakpoints.
Banche, Giuliana   +5 more
core   +1 more source

Plasmid-Mediated Spread of Carbapenem Resistance in Enterobacterales: A Three-Year Genome-Based Survey

open access: yesAntibiotics
The worldwide emergence and dissemination of carbapenem-resistant Gram-negative bacteria (CRGNB) is a challenging problem of antimicrobial resistance today.
Yancheng Yao   +6 more
semanticscholar   +1 more source

Antibiofilmogram of biofilm-producing urinary Enterobacterales

open access: yesBatna Journal of Medical Sciences (BJMS), 2023
Background. The organization of uropathogens into biofilm is responsible for their escape from immune defenses and the action of antibiotics (tolerance), as well as bacterial persistence causing chronic and recurrent infections. The objectives of our work were to identify, in a panel of urinary Enterobacterales: the formation of biofilm, its ...
openaire   +1 more source

Responses of Root Microbiome and Metabolome Are Linked to Crop Disease Severity

open access: yesJournal of Sustainable Agriculture and Environment, Volume 5, Issue 1, March 2026.
ABSTRACT Plant microorganisms are an essential component of the host and perform critical functions in plant development and health. Emerging evidence shows that plants use their root exudates to recruit beneficial microbes that protect them against abiotic and biotic stresses, including diseases.
Ayomide Emmanuel Fadiji   +1 more
wiley   +1 more source

Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae.

open access: yesEuropean Journal of Clinical Microbiology and Infectious Diseases
PURPOSE Real-world experience with meropenem/vaborbactam (M/V) is limited. Our aim is to report a clinical experience of M/V in the treatment of resistant Gram-negative bacilli.
G. Tiseo   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy